Anna‐Chloé Balageas

Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort

Thomas Desmidt, Julien Delrieu, Thibaud Lebouvier et al. · Neurobiology of Aging · 2019 · 26 citations · Full text

Medicine, Neurology, Neuroscience +13

Benzodiazepine use and neuroimaging markers of Alzheimer’s disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort

Quentin Gallet, Vincent Bouteloup, Maxime Locatelli et al. · Neuropsychopharmacology · 2021 · 26 citations · Full text

Medicine, Neurology, Neuroscience +17

Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes

Catherine Schramm, Camille Charbonnier, Aline Zaréa et al. · Genome Medicine · 2022 · 25 citations · Full text

Life Sciences, Biostatistics, Genetics +17

Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening

Gaël Nicolas, Aline Zaréa, Morgane Lacour et al. · Genetics in Medicine · 2024 · 23 citations · Full text

Life Sciences, Genetics, Neurology +17

Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers

Vincent Bouteloup, Nicolas Villain, Jean‐Sébastien Vidal et al. · JAMA Neurology · 2025 · 21 citations · Full text

Medicine, Clinical Sciences, Neurology +17